- US Capitol Capsule: Tobacco's 'free speech' fight may have biopharma implications
- Peeved Bayer to USTR: Indian govt picking winners
- Indian IP infrastructure upgrade underway
- Pre-emptive litigation in India: "extra-cautionary" or backdoor patent linkage?
COMMENT Other Informa Comment
JOB OF THE WEEK Promote your job vacancy